Undetectable Thyroglobulin Levels in Poorly Differentiated Thyroid Carcinoma Patients Free of Macroscopic Disease After Initial Treatment: Are They Useful?

Abstract

BACKGROUND:

Predictive role of undetectable thyroglobulin (Tg) in patients with poorly differentiated thyroid carcinoma (PDTC) is unclear. Our goal was to report on Tg levels following total thyroidectomy and adjuvant RAI in PDTC patients and to correlate Tg levels with recurrence.

METHODS:

Forty patients with PDTC with no distant metastases at presentation (M0) and managed by total thyroidectomy and adjuvant RAI were identified from a database of 91 PDTC patients. Of these, 31 patients had Tg values recorded and formed the basis of our analysis. A nonstimulated Tg level <1 ng/ml was used as a cutoff point for undetectable Tg levels. Association of patient and tumor characteristics with Tg levels was examined by χ (2) test. Recurrence-free survival (RFS) stratified by postop Tg level was calculated by Kaplan-Meier method and compared by log-rank test.

RESULTS:

Twenty patients had undetectable Tg (<1 ng/ml) and 11 had detectable Tg (≥1 ng/ml; range 2-129 ng/ml) following surgery. After adjuvant RAI, 24 patients had undetectable Tg (<1 ng/ml) and 7 had detectable Tg (≥1 ng/ml; range 1-57 ng/ml). Patients with undetectable Tg were less likely to have pathologically positive margins compared to those with detectable Tg (33 vs. 72 % respectively; p = 0.03). Patients with undetectable Tg levels had better 5-year regional control and distant control than patients with detectable Tg level (5-year regional recurrence-free survival 96 vs. 69 %; p = 0.03; 5-year distant recurrence-free survival 96 vs. 46 %, p = 0.11).

CONCLUSION:

Postoperative thyroglobulin levels in subset of patients with PDTC appear to have predictive value for recurrence. Patients with undetectable Tg have a low rate of recurrence.

• Authors: Tihana Ibrahimpasic, Ronald Ghossein, Diane L Carlson, Iain J Nixon, Frank L Palmer, Snehal G Patel, Robert M Tuttle, Ashok Shaha, Jatin P Shah, Ian Ganly
• Journal: Annals of surgical oncology (Ann Surg Oncol) Vol. 22 Issue 13 Pg. 4193-7 (Dec 2015) ISSN: 1534-4681 [Electronic] United States
• PMID: 25893415 (Publication Type: Journal Article)

Chemical References

• Biomarkers, Tumor
• Thyroglobulin

Topics

• Adenocarcinoma, Follicular (blood, pathology, surgery)
• Biomarkers, Tumor (blood)
• Carcinoma, Papillary (blood, pathology, surgery)
• Cell Differentiation
• Disease-Free Survival
• Female
• Follow-Up Studies
• Humans
• Male
• Middle Aged
• Neoplasm Staging
• Prognosis
• Retrospective Studies
• Thyroglobulin (blood)
• Thyroid Neoplasms (blood, pathology, surgery)
• Thyroidectomy